scispace - formally typeset
Journal ArticleDOI

Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: Towards the next generation HIV-1 inhibitors

Reads0
Chats0
TLDR
The identification of the first small molecules specifically designed to inhibit the HIV-1 replication by targeting the RNA binding site of the human DEAD-Box RNA helicase DDX3 is described.
About
This article is published in Bioorganic & Medicinal Chemistry Letters.The article was published on 2012-03-01. It has received 83 citations till now. The article focuses on the topics: RNA Helicase A & RNA.

read more

Citations
More filters
Journal ArticleDOI

DExD/H-box RNA helicases as mediators of anti-viral innate immunity and essential host factors for viral replication.

TL;DR: In an interesting twist, a lot of DExD/H-box helicases have also been identified as essential host factors for the replication of different viruses, suggesting that viruses ‘hijack’ their RNA helicase activities for their benefit.
Journal ArticleDOI

Multiple functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and viral infection.

TL;DR: The DEAD-box RNA helicase DDX3 is a multifunctional protein involved in all aspects of RNA metabolism, including transcription, splicing, mRNA nuclear export, translation, RNA decay and ribosome biogenesis, and could be a novel therapeutic target for the development of drug against HIV-1 and HCV.
Journal ArticleDOI

DDX3, a potential target for cancer treatment

TL;DR: There is concordance with in vitro evidence to support the hypothesis that DDX3 is associated with an aggressive phenotype in human malignancies, andDDX3 could be a druggable target for cancer treatment.
Journal ArticleDOI

Cancer the‘RBP'eutics–RNA-binding proteins as therapeutic targets for cancer

TL;DR: The current knowledge about RNA binding proteins and their role in tumorigenesis as well as the potential to target RBPs for cancer therapeutics are reviewed.
References
More filters
Journal ArticleDOI

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer

TL;DR: The discovery and continuing development of sorafenib is described, the first oral multikinase inhibitor that targets Raf and affects tumour signalling and the tumour vasculature.
Journal ArticleDOI

The DEAD-box protein family of RNA helicases

TL;DR: The description of the molecular characteristics of members of the DEAD-box protein family and on the enzymatic activities they possess gives insight into the regulation of ATP and RNA binding as well as in the ATPase and helicase activities.
Journal ArticleDOI

Requirement of DDX3 DEAD Box RNA Helicase for HIV-1 Rev-RRE Export Function

TL;DR: Evidence is presented that Rev/CRM1 activity utilizes the ATP-dependent DEAD box RNA helicase, DDX3, which functions in the CRM1 RNA export pathway analogously to the postulated role for Dbp5p in yeast mRNA export.
Journal ArticleDOI

The Crystal Structure of the Exon Junction Complex Reveals How It Maintains a Stable Grip on mRNA

TL;DR: Comparison with the structure of the eIF4AIII-Btz subcomplex that is determined reveals that large conformational changes are required upon EJC assembly and disassembly.
Related Papers (5)